General Information of Drug Off-Target (DOT) (ID: OTYIQT2F)

DOT Name Beta-1,4-galactosyltransferase 2 (B4GALT2)
Synonyms
Beta-1,4-GalTase 2; Beta4Gal-T2; b4Gal-T2; EC 2.4.1.-; Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase; Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase; EC 2.4.1.38; Lactose synthase A protein; EC 2.4.1.22; N-acetyllactosamine synthase; EC 2.4.1.90; Nal synthase; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2
Gene Name B4GALT2
Related Disease
Diabetic retinopathy ( )
Attention deficit hyperactivity disorder ( )
Colorectal carcinoma ( )
Uterine cervix neoplasm ( )
UniProt ID
B4GT2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.4.1.-; 2.4.1.22; 2.4.1.38; 2.4.1.90
Pfam ID
PF02709 ; PF13733
Sequence
MSRLLGGTLERVCKAVLLLCLLHFLVAVILYFDVYAQHLAFFSRFSARGPAHALHPAASS
SSSSSNCSRPNATASSSGLPEVPSALPGPTAPTLPPCPDSPPGLVGRLLIEFTSPMPLER
VQRENPGVLMGGRYTPPDCTPAQTVAVIIPFRHREHHLRYWLHYLHPILRRQRLRYGVYV
INQHGEDTFNRAKLLNVGFLEALKEDAAYDCFIFSDVDLVPMDDRNLYRCGDQPRHFAIA
MDKFGFRLPYAGYFGGVSGLSKAQFLRINGFPNEYWGWGGEDDDIFNRISLTGMKISRPD
IRIGRYRMIKHDRDKHNEPNPQRFTKIQNTKLTMKRDGIGSVRYQVLEVSRQPLFTNITV
DIGRPPSWPPRG
Function Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. Can produce lactose.
Tissue Specificity Weakly expressed in various tissues. Highest expression in prostate, testis, ovary, intestine, muscle, and in fetal brain.
KEGG Pathway
Galactose metabolism (hsa00052 )
N-Glycan biosynthesis (hsa00510 )
Various types of N-glycan biosynthesis (hsa00513 )
Other types of O-glycan biosynthesis (hsa00514 )
Mannose type O-glycan biosynthesis (hsa00515 )
Glycosaminoglycan biosynthesis - keratan sulfate (hsa00533 )
Glycosphingolipid biosynthesis - lacto and neolacto series (hsa00601 )
Metabolic pathways (hsa01100 )
Reactome Pathway
N-Glycan antennae elongation (R-HSA-975577 )
Keratan sulfate biosynthesis (R-HSA-2022854 )
BioCyc Pathway
MetaCyc:HS04130-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Diabetic retinopathy DISHGUJM Definitive Biomarker [1]
Attention deficit hyperactivity disorder DISL8MX9 Strong Genetic Variation [2]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [3]
Uterine cervix neoplasm DIS0BYVV Strong Biomarker [4]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Beta-1,4-galactosyltransferase 2 (B4GALT2). [5]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Beta-1,4-galactosyltransferase 2 (B4GALT2). [15]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [6]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [7]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [8]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [9]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [10]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [11]
Progesterone DMUY35B Approved Progesterone decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [12]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [13]
SNDX-275 DMH7W9X Phase 3 SNDX-275 decreases the expression of Beta-1,4-galactosyltransferase 2 (B4GALT2). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy.Diabetes. 2004 Nov;53(11):2968-76. doi: 10.2337/diabetes.53.11.2968.
2 Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder.Brain Sci. 2019 Oct 22;9(10):288. doi: 10.3390/brainsci9100288.
3 Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer.Sci Rep. 2016 Mar 23;6:23642. doi: 10.1038/srep23642.
4 beta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization.Biochem Biophys Res Commun. 2007 Jun 22;358(1):41-6. doi: 10.1016/j.bbrc.2007.04.044. Epub 2007 Apr 18.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
7 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
8 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
11 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
12 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
13 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
14 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
15 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.